StocksMedium•5 November 2026•
1 min read
InMed Pharmaceuticals Stock Under Pressure After Q1 Loss and Liquidity Warning
Key Facts
1InMed Pharmaceuticals reported a net loss of $2.33 million for the first quarter of fiscal 2027.
2The company expects its cash reserves to fund operations only into mid-November.
InMed Pharmaceuticals reported a net loss of $2.33 million for the first quarter of fiscal 2027. Benzinga reported that the company expects its existing cash reserves to fund operations only into mid-November, necessitating immediate financial adjustments or new funding.
The stock INM closed at $1.75 on November 4, 2026, after trading between a session low of $1.62 and a high of $1.83. These financial results and the accompanying liquidity warning highlight significant pressure on the company's balance sheet as it nears the end of its current cash runway.